Combination therapy of fasudil hydrochloride and ozagrel sodium for cerebral vasospasm following aneurysmal subarachnoid hemorrhage

Neurologia Medico-Chirurgica

Volumn 38, Issue 12, 1998, Pages 805-811

  Nakashima, Susumu ^a,b   Tabuchi, Kazuo ^a   Shimokawa, Shoko ^a   Fukuyama, Kouzou ^a   Mineta, Toshihiro ^a   Abe, Masamitsu ^a  

^a SAGA UNIVERSITY   (Japan)

^b OKAYAMA KYOKUTO HOSPITAL   (Japan)

Author keywords

Combination therapy; Fasudil hydrochloride; Ozagrel sodium; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

DOPAMINE; FASUDIL; OZAGREL;

ADULT; AGED; ARTICLE; CALCIUM ANTAGONISM; CALCIUM CELL LEVEL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM;

EID: 0032431683     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.38.805     Document Type: Article

References (28)

1. Allen GS, Ahn HS, Preziosi TJ, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR: Cerebral arterial spasm. A controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308: 619-624, 1983
2. Asano T, Ikegaki I, Satoh S, Mochizuki D, Hidaka H, Suzuki Y, Shibuya M, Sugita K: Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain. Br J Pharmacol 103: 1935-1938, 1991
3. Asano T, Ikegaki I, Satoh S, Suzuki Y, Masato S, Takatasu M, Hidaka H: Mechanism of action of a novel antivasospasm drug, HA 1077. J Pharmacol Exp Ther 241: 1033-1040, 1987
4. Auer LM, Schneider GH, Auer T: Computerized tomography and prognosis in early aneurysm surgery. J Neurosurg 65: 217-221, 1986
5. Findlay JM, Weir BKA, Kanamaru K, Grace M, Baughman R, Pharm D: The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 26: 201-206, 1990
6. Findlay JM, Weir BKA, Steinke D, Tanabe T, Gordon P, Grace M: Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69: 723-735, 1988
7. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1-9, 1980
8. Fukumori T, Tani E, Maeda Y, Suenaga A: Effect of selective inhibitor of thromboxane A2 synthetase on experimental cerebral vasospasm. Stroke 15: 306-311, 1984
9. Hunt WE, Kosnik EJ: Timing and perioperative care in intracranial aneurysm surgery. Clin Neurosurg 21: 79-89, 1974
10. Jan M, Buchheit F, Tremoulet M: Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosugery 23: 154-157, 1988
11. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1: 480-484, 1975
12. Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL: The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 73: 18-36, 1990
13. Kassell NF, Torner JC, Jane JA, Haley EC, Adams HP: The international cooperative study on the timing of aneurysm surgery. Part 2: Surgical results. J Neurosurg 73: 37-47, 1990
14. Kawano T, Ono H, Mori K, Iwayama K, Handa H, Yonekawa Y, Okamoto S, Yasunaga A, Kaneko M, Tanaka K, Kikuchi H, Yamashita T, Maki Y, Nose T, Kobayashi E, Yokoyama H, Matsumoto H, Waga S: [Phase II trial of the thromboxane synthetase inhibitor, OKY-046 on delayed vasospasm following ruptured cerebral aneurysm]. Shinyaku To Rinsho 35: 762-774, 1986 (Jpn, with Eng abstract)
15. Ljunggren B, Brandt L, Saveland H, Nilsson P, Cronqvist S, Andersson K, Vinge E: Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. J Neurosurg 61: 864-873, 1984
16. Ohta T, Kikuchi H, Hashi K, Kudo Y: Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study. J Neurosurg 64: 420-426, 1986
17. Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Miller JD, Hunter KM, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68: 505-517, 1988
18. Rahwan RG, Witiak DT, Muir WW: Calcium antagonists. Annu Rep Med Chem 16: 257-268, 1981
19. Saito I, Asano T, Ochiai C, Takakura K, Tamura A, Sano K: A double-blind clinical evaluation of the effect of nizofenon on delayed ischemic neurological deficits following aneurysmal rupture. Neurol Res 5: 29-47, 1983
20. Sasaki T, Wakai S, Asano T, Takakura K, Sano K: Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581. J Neurosurg 57: 74-82, 1982
21. Satoh S, Suzuki Y, Ikegaki I, Asano T, Shibuya M, Sugita K, Hidaka H: The effect of HA 1077 on the cerebral circulation after subarachnoid haemorrhage in dogs. Acta Neurochir (Wien) 110: 185-188, 1991
22. Seifert V, Eisert WG, Stolke D, Goetz C: Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25: 590-598, 1989
23. Shibuya M, Suzuki Y, Sugita K, Saito I, Tomio S, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H, Nakashima M: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76: 571-577, 1992
24. Shibuya M, Suzuki Y, Takayasu M, Asano T, Harada T, Ikegaki I, Satoh S, Hidaka H: The effect of intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs. Acta Neurochir (Wien) 90: 53-59, 1988
25. Takakura K, Sugita K, Kikuchi H, Saito I, Shibuya M, Suzuki Y, Sasaki T, Takemae T, Nagata I, Nakashima M: [Effect of AT-877 on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal trial]. Yakuri To Chiryo 20 (Suppl): s1627-1658, 1992 (Jpn)
26. Takayasu M, Suzuki Y, Shibuya M, Asano T, Kanamori M, Okada T, Kageyama N, Hidaka H: The effect of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 65: 80-85, 1986
27. Yonekawa Y, Handa H, Okamoto S, Ohta T, Kamijo Y, Oda Y, Kondo A, Nin K, Yamamoto T, Ban S, Nakao S, Ohtsuka S, Kikuchi H, Shishido H, Yoneda S: [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor. Clinical study among multiple institutions]. Nippon Geka Hokan 55: 473-484, 1986 (Jpn, with Eng abstract)
28. Yoshida Y, Ueki S, Takahashi A, Takagi H, Torigoe H, Kudo S: [Intrathecal irrigation with urokinase in ruptured cerebral aneurysm cases]. Neurol Med Chir (Tokyo) 25: 989-997, 1985 (Jpn, with Eng abstract)